Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer - Episode 7

Informed Decision-Making in HR+ Breast Cancer

Kevin Kalinsky, MD, MS, of Emory Winship Cancer Institute, discusses treatment options for HR-positive/HER2-negative breast cancer and comments on the evolving role of genomic testing in regard to treatment selection.